Free Trial

Philips (PHIANA Baa1/BBB+): 2Q24 Preview (29th July)

HEALTHCARE
  • 2Q Revenues are expected to be flat yoy at €4,446 with no significant outliers in the 3 business units.
  • Philips share price has moved ahead of analysts' earnings expectations which either sets up for a disappointment or a sign that analysts are too conservative.
  • Exor and Artisan have both amassed significant stakes as value investors betting on a turn-around in the business.
  • Ratings were placed on Stable by Moody's and S&P in May and July
  • Better earnings predictability after agreement on the sleep apnoea legal claims.
  • Expect to see ongoing cost-savings.
  • Moody's anticipate leverage maintained at 2-3x over the next 1-2yrs.
  • Last issued in May '24 to refi existing debt.
  • Nothing falls due until Mar '25.
  • Bonds trade more or less in-line with BDX which is 1 notch lower rated but 3x the size.

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.